Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,593,660
-
Share change
-
-1,176,412
-
Total reported value
-
$35,401,968
-
Price per share
-
$1.64
-
Number of holders
-
38
-
Value change
-
-$2,158,081
-
Number of buys
-
9
-
Number of sells
-
22
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q2 2021
As of 30 Jun 2021 LEAP THERAPEUTICS INC - COM (LPTX) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,593,660 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, HHLR ADVISORS, LTD., Artal Group S.A., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, BAKER BROS. ADVISORS LP, Opaleye Management Inc., BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA ADVISERS, LP.
This table shows 38 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.